Healthcare
MindWalk Holdings Corp.(HYFT)
Live Price
Offline$1.53
+2.00% today
Window Change
+24.00%
Window
May 5, 2026 โ Jun 24, 2026
- Market Cap
- $80.00M
- Revenue Growth
- -2.0%
- EPS Growth
- +12.6%
- Dividend Yield
- 0.0%
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 35 bars ยท May 5, 2026 โ Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
MindWalk Holdings Corp. (HYFT) is a Healthcare stock with a market cap of $80.00M and listed on NASDAQ. The stock last traded around $1.53 and up 24.0% across the available one-year price window (May 5, 2026 โ Jun 24, 2026). Baseline metrics include revenue growth of -2.0%, EPS growth of +12.6%, a dividend yield of 0.0%. What stands out right now is revenue -2.0%, EPS +12.6%, free cash flow -27.8% with operating margin -66.0% and ROIC -63.4%. Valuation sits in the middle of the pack at price/sales 4.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines HYFT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-2.0% vs +7.6% peer median
Operating Margin
Below sector median
-66.0% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report came in below the EPS bar
2026 was reported on Mar 12, 2026 with an EPS surprise of -50.0% and a revenue surprise of -9.8%.
The operating picture looks softer than before
Revenue is at -2.0% and EPS is at +12.6%, with operating margin around -66.0%.
The next real check-in already has a date
The next earnings event is scheduled for Jul 23, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Benchmark Edge
HYFT vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
HYFT
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
HYFT Max Drawdown
-25.38%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for HYFT and SPY.
Company Overview
MindWalk Holdings Corp.
NASDAQ Global Market
MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
- Leadership
- Jennifer Lynne Bath
- IPO Date
- Jan 7, 2002
- Employees
- 102
- Street Address
- 3204 - 4464 Markham St.
- Mailing
- Victoria, BC, V8Z 7X8
- Region
- Victoria, BC, CA
- Reporting Currency
- USD
- Investor Line
- 604-806-0626
- Last Updated
- Apr 30, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 4.1
- Price/Book
- 5.0
Growth
- Revenue
- -2.0%
- EPS
- +12.6%
- Free Cash Flow
- -27.8%
Profitability
- Gross Margin
- 59.7%
- Operating Margin
- -66.0%
- Net Margin
- -66.8%
- ROE
- -63.1%
- ROIC
- -63.4%
Balance Sheet
- Debt/Equity
- 0.24
- Current Ratio
- 3.74
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.